Hillsdale Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-90
| Closed | -$6.16K | – | 714 |
|
|
2024
Q2 | $6.16K | Buy |
90
+10
| +13% | +$685 | ﹤0.01% | 534 |
|
|
2024
Q1 | $5.54K | Hold |
80
| – | – | ﹤0.01% | 564 |
|
|
2023
Q4 | $5.73K | Sell |
80
-50,620
| -100% | -$3.63M | ﹤0.01% | 515 |
|
|
2023
Q3 | $2.64M | Buy |
50,700
+2,240
| +5% | +$117K | 0.24% | 153 |
|
|
2023
Q2 | $3.07M | Sell |
48,460
-36,140
| -43% | -$2.29M | 0.28% | 141 |
|
|
2023
Q1 | $4.58M | Sell |
84,600
-11,300
| -12% | -$612K | 0.39% | 89 |
|
|
2022
Q4 | $5.08M | Buy |
95,900
+1,900
| +2% | +$101K | 0.43% | 66 |
|
|
2022
Q3 | $4.37M | Buy |
94,000
+79,900
| +567% | +$3.72M | 0.4% | 89 |
|
|
2022
Q2 | $805K | Buy |
+14,100
| New | +$805K | 0.06% | 212 |
|